Eric Scott Allen

US Patent:

20110097134, Apr 28, 2011

Filed:

Sep 17, 2010

Appl. No.:

12/884891

Inventors:

Eric Evan ALLEN - Simi Valley CA, US
Edward G. Maliski - Thousand Oaks CA, US

International Classification:

B43K 8/00

US Classification:

401 23

Abstract:

The present invention is a class of highlighting devices that contain radiocontrast agents and a carrier medium. These devices may be used to highlight, mark, identify, or map external, but radiotransparent or radiolucent structures so that they are indicated in x-ray radiographic images.

US Patent:

20130108560, May 2, 2013

Filed:

Nov 1, 2012

Appl. No.:

13/666746

Inventors:

Robert Davidson - Woodland Hills CA, US
Eric Allen - Camarillo CA, US
Ed Maliski - Thousand Oaks CA, US

International Classification:

A61K 8/44
A61Q 11/00
C07C 321/04
C07C 229/36
C07C 229/08
C07D 209/20

US Classification:

424 54, 562575, 548496, 562559, 562445

Abstract:

A thin film composition for oral administration that adheres to and dissolves in a mouth of a user, wherein the thin film is a single layered water-soluble solid comprising at least one D-amino acid contained in a plurality of hydrophobic carriers dispersed throughout the thin film. The hydrophobic carriers comprise oil and the composition further comprises a phospholipid, an emulsifier, and a water soluble polymer. The preferred D-amino acids are D-leucine, D-tryptophan, D-methionine, and D-tyrosine. A method of reducing dental plaque in a subject entails placing the thin film composition contemplated herein into a mouth of the subject.

US Patent:

20130309363, Nov 21, 2013

Filed:

Mar 25, 2013

Appl. No.:

13/850289

Inventors:

Robert Davidson - Woodland Hills CA, US
Eric Allen - Camarillo CA, US
Edward Maliski - Thousand Oaks CA, US
Jose Bernado - Thousand Oaks CA, US

International Classification:

A23L 1/29

US Classification:

426 74, 426573, 426575, 426576, 426577

Abstract:

The present invention relates to oral dosage formulations consisting of at least one active ingredient contained in a plurality of hydrophobic carriers dispersed in an aqueous medium comprising a hydrocolloid. The active ingredients include various forms of electrolytes. The formulations may further include emulsifiers, permeation enhancers, and vasodilators. The invention further relates to methods of making the oral dosage formulations.

US Patent:

20150174068, Jun 25, 2015

Filed:

Sep 12, 2012

Appl. No.:

14/344455

Inventors:

Robert S. Davidson - Woodland Hills CA, US
Eric Allen - Camarillo CA, US
Jose Bernado - Thousand Oaks CA, US
Edward Maliski - Thousand Oaks CA, US

Assignee:

CURE IP HOLDINGS, LLC - Oxnard CA

International Classification:

A61K 9/127
A61K 36/76
A61K 31/455
A61K 31/337
A61K 31/08
A61K 47/24
A61K 31/565
A61K 31/355
A61K 38/28
A61K 47/36
A61K 47/10
A61K 47/46
A61K 31/522
A61K 31/519

Abstract:

In accordance with a composition aspect of the invention, a composition for applying to skin comprises one or more pharmaceutically active ingredients contained in a plurality of hydrophobic carriers dispersed throughout a hydrogel, a skin permeation enhancer for enhancing the permeation of the active ingredients into skin, and an emulsifier. The amount of hydrogel is sufficient to allow the hydrogel to dry to as a substantially continuous film over and in contact with the skin to which it is applied. Related method and apparatus aspects are also described.

US Patent:

20140121191, May 1, 2014

Filed:

Mar 25, 2013

Appl. No.:

13/850292

Inventors:

Robert Davidson - Woodland Hills CA, US
Eric Allen - Camarillo CA, US
Edward Maliski - Thousand Oaks CA, US
Jose Bernado - Thousand Oaks CA, US

International Classification:

A61K 31/555
A61K 31/045
A61K 45/06
A61K 31/44
A61K 31/4985
A61K 31/455
A61K 31/522

US Classification:

514185, 514356, 51426334, 514277, 514249, 51426331

Abstract:

The present invention relates to oral dosage formulations consisting of at least one active ingredient contained in a plurality of hydrophobic carriers dispersed in an aqueous medium comprising a hydrocolloid. The active ingredients include various energy supplements, such as caffeine and vitamins. The formulations may further include emulsifiers, permeation enhancers, and vasodilators. The invention further relates to methods of making the oral dosage formulations.

Address:

17010 Sandestine Dr, Houston, TX 77095

VIN:

2GCEC13J271607040

Make:

CHEVROLET

Model:

SILVERADO 1500

Year:

2007